AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Herclon Injection

Prescription Icon
Prescription Required

Marketer

Roche Products India Pvt Ltd

Salt Composition

Trastuzumab (440mg)

Overview Herclon Injection

Oncaspar injection is indicated for the management of breast and gastric cancers. Its mechanism involves targeting and eliminating cancerous cells through HER2 (human epidermal growth factor receptor 2) inhibition. Administration is strictly by injection, under the supervision of a qualified healthcare professional. Dosage and frequency are determined individually by your physician, based on your specific condition and may be adjusted. Adhere strictly to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be immediately apparent, potentially requiring weeks or months; discontinue only under medical direction. Commonly reported side effects include nausea, cephalalgia, dermatological reactions, sleep disturbances, and increased infection risk. The medication can decrease blood cell counts (red and white blood cells), heightening susceptibility to infections. Regular blood tests, including blood cell counts, cardiac function, liver function, and uric acid levels are essential. Report immediately any shortness of breath, cough, chills, or limb edema. Inform your healthcare provider of all concurrent medications, as drug interactions are possible. This medication is contraindicated during pregnancy and lactation. Reliable contraception is crucial for both partners throughout the treatment period. A patient support program, facilitated by Tata 1mg, is available in India; contact your physician or call 1800-102-1618 for further information.

Primary Ingredients of Herclon Injection

No text was provided to rewrite.

Uses of Herclon Injection

Cancers affecting the breast and stomach.

Major Benefits of Herclon Injection:

This medication will be administered by your healthcare provider; please do not attempt self-medication.

Common Side effects of Herclon Injection:

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

How to use Herclon Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

How Herclon Injection works:

Herclon Injection, a genetically engineered IgG1 monoclonal antibody, targets HER2 receptors—human epidermal growth factor receptor 2 proteins—that fuel excessive cell growth in breast and gastric cancers. By blocking HER2, it eliminates cancer cells and concurrently disrupts multiple downstream signaling pathways implicated in cancer development.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Herclon Injection and alcohol may lead to significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Herclon Injection during pregnancy is contraindicated due to established risks to fetal development. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is mandatory.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Herclon Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Herclon Injection's effect on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

The use of Herclon Injection in individuals with kidney impairment appears to pose minimal risk. Preliminary findings indicate dose modification may not be necessary; however, physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Data regarding Herclon Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Herclon Injection :

Omit a Herclon Injection dose? Seek your physician's advice.

Facts to Know About Herclon Injection

LabelValue
Chemical Category Monoclonal antibody
Developing Habits No.
Treatment Category Cancer Medications
Actions Monoclonal antibody HER2/neu (ErbB2) inhibitor

FAQs on Herclon Injection

Herclon Injection may cause side effects including sore throat, fever, chills, fatigue, pale skin, nosebleeds, unusual bruising or bleeding, stomach pain, seizures, hallucinations, muscle cramps and spasms, nausea or vomiting, loss of appetite, rapid heartbeat, discolored or decreased urine output, painful urination, and other signs of infection. Contact your doctor immediately if you experience any of these symptoms.
Effective contraception is recommended for women of childbearing age throughout Herclon Injection therapy and for seven months afterward. Pregnancy planning may resume seven months post-treatment.
Herclon Injection should be administered to early-stage breast cancer patients for one year, or until disease recurrence, whichever comes first. Treatment should not exceed one year.
Herclon Injection does not require fasting beforehand. Administration must be performed by a qualified healthcare professional, under the supervision of a physician experienced in cancer chemotherapy.
Herclon Injection comes in two formulations: intravenous (IV) infusion and subcutaneous injection. Always verify the correct formulation is administered per your prescription. The IV formulation is for intravenous use only; it must not be given subcutaneously. Your doctor can change your treatment between IV and subcutaneous Herclon Injection as needed.
Herclon Injection, a monoclonal antibody, targets the human epidermal growth factor receptor 2 (HER2) protein found on some cancer cells. Because it works by binding to HER2 to inhibit cancer growth, it's only effective in patients with HER2-positive cancer; it's not indicated for HER2-negative cancers.
Using Herclon Injection with anthracycline-based cancer drugs (like doxorubicin) can harm your heart. Therefore, your doctor must assess your heart health before and throughout treatment.
Cardiac evaluations are required at treatment initiation, every three months during treatment, and every six months post-treatment for 24 months following the final Herclon Injection. Patients with pre-existing cardiac conditions need evaluations every 12 weeks.
Herclon Injection
47,100
MRP 54,650
13% off